A new artificial intelligence software that will help doctors to make quicker and more accurate decisions when diagnosing potentially cancerous lung lesions, has received major government funding. This is a…
A paper published in Lung Cancer demonstrates the ability of Optellum’s Lung Cancer Prediction artificial intelligence (AI) to classify lung nodule malignancy. As discussed in earlier news stories, there has…
Professor Sam Janes, a leading clinician and University College London academic will presenting a poster to American Society of Clinical Oncology (ASCO) annual meeting on identifying adenocarcinoma with AI. Collaborators include Vanderbilt University Medical Center,…
Join us on June 23rd at 1pm EST for a webinar where expert clinical speakers will discuss the evidence, clinically-validated in multi center studies, and a case study in implementation…
The National Consortium of Intelligent Medical Imaging (NCIMI) podcast provides expert insights on the future of #AI in healthcare. In episode six CEO Dr Claire Bloomfield speaks to Optellum CEO…
Oxford-based company Optellum, supported by NHS collaborations and grant funding, launches the world’s first AI decision support for early lung cancer • Ground-breaking machine-learning neural network can recognise the signs…
Optellum is excited to be working with a leading hospital on the first clinical installation of Virtual Nodule Clinic (VNC). Over the past 8 months, Optellum's Virtual Nodule Clinic (VNC)…
Healthcare UK, part of the Department for International Trade (DIT), has launched a programme to showcase the UK's leading digital health companies. Digital Health and Artificial Intelligence is seen as the answer to many of the challenges facing global…
2020 was an extraordinary year and, looking back, while it was dominated by the world health crisis of the pandemic there were also colossal achievements in healthcare and medical technology;…
Optellum is proud to be a key industry partner in a £11M University of Oxford-led AI programme to accelerate lung cancer diagnosis. NHS England and three industry leaders, Optellum, Roche,…
Optellum team and advisors took the lead role in preparing the winning bid, with Optellum Chairman, Prof Sir Michael Brady FRS named the Executive Chairman of the NCIMI consortium led…
EIT Health LUCINDA (Early Lung Cancer Diagnosis with Artificial Intelligence and Big Data) is a consortium of leading clinicians & hospitals in the UK, the Netherlands and Germany (Oxford University…